Ad is loading...
MENU
AURX
Stock ticker: OTC
PRICE
CHANGE
CAPITALIZATION

Nuo Therapeutics (AURX) Ownership - Who owns Nuo Therapeutics?

Profile

Industry
N/A
Address
8285 El Rio
Phone
+1 346 396-4770
Employees
10
Web
https://www.nuot.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
36.23M
P/E Ratio
N/A
Total Cash
473.04K
Projected Growth
N/A
Total Debt
194.04K
Revenue
1.03M
Risk (Beta)
-892.47
Dividend Yield
N/A
Total Cash/Share
0.01
Total Debt/Equity
N/A
Revenue/Share
0.03 USD as % of share price

Fundamentals

AURX
Capitalization
36.2M
P/E Ratio
N/A
Risk (Beta)
-892.47
Dividend Yield
N/A
Total Cash
473K
Total Cash/Share
0.01
Total Debt
194K
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.03%
Revenue
1.03M
ROE
N/A
Book Value
599K
P/B Ratio
40.65
Cash Flow
N/A
Earnings
-0.07
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
4.55K
Current Ratio
1.70
Current Revenue Per Employee
40530.33
Dividends Per Share - Security
N/A
EBITDA
-2.59M
Float
N/A
Float - Current
N/A
Gross Income Margin
82.09
Revenue To Assets
-191.94
Shares Held By Institutions
1.77K
Shares Outstanding - Current
46.6M
Total Liabilities
822K
Total Volume MTD
N/A
Value
-1
Gain YTD
41.364
View a ticker or compare two or three
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
8285 El Rio
Phone
+1 346 396-4770
Employees
10
Web
https://www.nuot.com